Taking people in ChinaNo phase
Testing a New Mass Spectrometry Method for Myeloma Protein Monitoring
Tests a blood method to detect and track abnormal proteins in multiple myeloma.
Plain-language title generated from the registry record
Registry title: Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis
Key facts
- Where
- Guangzhou, ChinaSee the site
Where in China
- Zhujiang Hospital of Southern Medical UniversityGuangzhou, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Zhujiang Hospital
- Trial code
- NCT05686447
- Record updated
- 6 April 2025
- Original description
To provide a comprehensive MALDI-TOF mass spectrometry method for detecting, characterizing, and quantifying M-protein, and to track M-protein in a very sensitive and specific manner during patient treatment, providing a more precise test for diagnosing disease and monitoring patient response to treatment.Read full original descriptionShow less
Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis
To provide a comprehensive MALDI-TOF mass spectrometry method for detecting, characterizing, and quantifying M-protein, and to track M-protein in a very sensitive and specific manner during patient treatment, providing a more precise test for diagnosing disease and monitoring patient response to treatment.
Inclusion: -.
Exclusion: -.